Invitation to Sponda’s Q2/2013 result presentation and

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Invitation to Sponda’s Q2/2013 result presentation and conference call

Sponda Plc                  Investor news   26 July 2013 at 09:15 a.m.  

Invitation to Sponda’s Q2/2013 result presentation and conference call   

Sponda Plc will publish interim report for the period of January-June 2013 on Friday, 2 August 2013 at approximately 8:30 Eastern European time. 

A meeting for analysts and press will be held in Finnish on Friday, 2 August 2013 at 9:30 Eastern European time at Sponda, Korkeavuorenkatu 45, Helsinki. The financial report and other material will be available on the company website at www.sponda.fi after publication.

An international conference call and webcast for analysts and investors will be held on Friday, 2 August 2013 at 11:00 Eastern European time. To join the conference call, please call +44 (0)20 7162 0077, Confirmation Code: 933415, and to join the webcast, please go to “Sponda’s webcast”

A replay of the conference call and webcast will be available at www.sponda.fi >Investors >Performance >Results and presentations.

Sponda Plc

Further information: Pia Arrhenius, Senior Vice President, Corporate Communications and IR, tel: +358 20 431 3454

Sponda Plc is a property investment company that specialises in commercial properties in the largest cities in Finland and Russia. Sponda's business concept is to own, lease and develop office, retail and logistics properties in environments that promote the business success of its clients. The fair value of Sponda's investment properties is approximately EUR 3.3 billion and the leasable area is around 1.5 million m².

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Ovation's Roadmap for Revitalizing Rural Healthcare

Updated Category News Views 5

Steering Rural Healthcare Towards a Brighter Future Alright, here we are with Ovation Healthcare trying to inject some much-needed life into the sometimes forgotten corners of the healthcare world—those rural hospitals. They’ve cooked up a fresh white paper, and it’s got the makings of a lifeline for these institutions swirling in red ink. The financial landscape...

Continue Reading
ProperHeir Expands with New Innovative Office Space

Updated Category News Views 194

ProperHeir Expands with New Innovative Office Space ProperHeir has recently announced an exciting development with the opening of its new office at the Miramar Tech Center. This expansion marks a significant milestone as the company has tripled its available space. The chief purpose of this new office is to effectively host its growing in-house sales team and provide a...

Continue Reading
Discover How Octa Transforms Forex Trading for Singaporeans

Updated Category News Views 95

Understanding the Forex Market The foreign exchange market, commonly known as forex, stands as the largest and most dynamic financial market in the world. It allows traders to buy and sell currencies, leveraging the fluctuations in exchange rates to boost their earnings. Operating continuously from Monday to Friday, this market presents individual traders with the chance...

Continue Reading
Seoul Business Agency Powers Startups at the CES 2026 Pavilion

Updated Category News Views 176

Seoul Business Agency Showcases Startups at CES 2026 Pavilion The Seoul Business Agency (SBA) has taken ambitious strides to support the innovative spirit of Seoul's startups at CES 2026. Engaging with 19 prestigious institutions within Seoul’s ecosystem, the SBA is dedicated to empowering 70 startups as they venture onto the global stage. The 'Seoul POP' themed...

Continue Reading
VYJUVEK® Receives Groundbreaking Approval for DEB Treatment

Updated Category News Views 252

VYJUVEK® Approved for Dystrophic Epidermolysis Bullosa Treatment VYJUVEK approved for DEB treatment from birth, offering flexible home administration options for patients and their families. This breakthrough marks VYJUVEK as the first genetic medicine approved in Japan for DEB. Recently, Krystal Biotech, Inc. (NASDAQ: KRYS) announced that its innovative treatment,...

Continue Reading